Project description
A comprehensive strategy for accurate diagnosis of COVID-19 and other respiratory diseases
COVID-19, the infectious disease caused by the most recently discovered coronavirus, has spread to more than 200 countries worldwide. Detecting and differentiating Sars-CoV-2 from SARS-CoV, which emerged in November 2002, as well as 30 other common respiratory bacteria and viruses, is important. Failure to distinguish different pathogens may lead to unnecessary antimicrobial use, cross-infection of mis-grouped patients and further spreading of infectious disease. The EU-funded RAPID-COVID project will prototype a technique to simultaneously detect and differentiate SARS-CoV-2 and 30 other common respiratory bacteria and viruses. It will allow for accurate, cost-effective and comprehensive diagnoses during the current outbreak as well as for streamlined integration into future routine diagnoses of respiratory diseases.
Fields of science
- natural sciencesbiological sciencesmicrobiologybacteriology
- natural sciencesbiological sciencesmicrobiologyvirology
- social sciencessociologyindustrial relationsautomation
- medical and health scienceshealth sciencesinfectious diseasesRNA virusescoronaviruses
- medical and health sciencesbasic medicinepathology
Keywords
Programme(s)
Topic(s)
Funding Scheme
RIA - Research and Innovation action
Coordinator
OX14 3DB Abingdon
United Kingdom
See on map
Participants (4)
93230 Romainville
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
1000 Ljubljana
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
29603 Marbella Malaga
See on map
75012 Paris
See on map